{"nct_id":"NCT00548405","title":"Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two","status":"COMPLETED","status_verified_date":"2017-03","start_date":"2007-10","start_date_type":null,"primary_completion_date":"2011-09","primary_completion_date_type":"ACTUAL","completion_date":"2011-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}